Ellevest Inc’s Inozyme Pharma INZY Stock Holding History

Ellevest Inc’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-76	Closed	–	–	1719
2022 Q2	$0	Buy	76 +38	+100%	+$165	﹤0.01%	1522
2022 Q1	$0	Buy	+38	New	+$224	﹤0.01%	1513

Other funds holding INZY

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ellevest Inc's INZY Position: Q3 2022 in Review

Ellevest Inc sold out of Inozyme Pharma (INZY) in Q3 2022, closing a stake of 76 shares.

Ellevest Inc first reported a position in INZY in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 39 funds tracked by Wall St. Rank hold INZY as of Q3 2022.

Ellevest Inc reported no remaining Inozyme Pharma position as of Q3 2022 after selling out during the quarter.
Ellevest Inc sold 76 Inozyme Pharma shares in Q3 2022.
Ellevest Inc first reported a position in Inozyme Pharma in Q1 2022 and held it in 2 quarters.
Ellevest Inc's Inozyme Pharma position peaked at $0 in Q2 2022.
39 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.